Komatsu, Akira
Toyonaga, Takahiko
Sumiyoshi, Natsuki
Tanaka, Miho
Shibuya, Naoki
Saruta, Masayuki
Article History
Received: 11 July 2023
Accepted: 2 January 2024
First Online: 3 January 2024
Competing interests
: T.T. received research grants from Mitsubishi Tanabe Co., Ltd., and Pfizer Inc. M. S. received lecture fees from Janssen Pharma K.K., Takeda Pharmaceutical Co.,Ltd., Mitsubishi Tanabe Pharma Co., Ltd., and EA Pharma Co., Ltd., advisory/consulting board fees from EA Pharma Co., Ltd., and grants from Zeria Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co.,Ltd., EA Pharma Co., and Ltd. EP-CRSU Co., Ltd. All other authors declare no competing interest.